A research team has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein […]

FiercePharmaAsia—Gilead’s remdesivir licensing; Legend’s $100M IPO; Takeda’s blockbuster hopefuls aliu Fri, 05/15/2020 – 07:57

Univercells inks deal to produce prefabricated vaccine facilities for potential COVID-19 shot kblankenship Fri, 05/15/2020 – 10:53

Blueprint’s Ayvakit gets FDA no-go in new stomach cancer use but presses ahead in blood disorder aliu Fri, […]

bmj;369/may15_8/m1982/FAF1faMichael Antony Rollin Taylor was head boy at Holme Valley Grammar School. Before his consultant career at Macclesfield […]

‘There is a hard road ahead for both the NHS and the whole care system,’ says the NHS […]

The decision brings a ‘much needed’ new treatment option to this patient community

Data show a 56.6% drop in attendances compared to a year ago

The firm will work with Vrije Universitat to produce a reformulated version of imatinib and test it in […]

Staff without specific training to draw arterial blood can use Roche v-TAC for blood gas analysis